Sangamo Therapeutics (0R1D.LSE) Q3 2024 Earnings

Aug 6Confirmed
Q2 2024
Q3 2024
-0.27
-0.23
-0.19
-0.15

Details

Expected EPS
-0.146729
Actual EPS
-0.18
Surprise EPS
-0.03
Surprise Percent
-22.68%

Description

⁨Sangamo Therapeutics⁩ (⁦0R1D.LSE⁩) has reported earnings of ⁦-0.18⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts